[go: up one dir, main page]

FR2843301B1 - Forme galenique pour la delivrance colique de principes actifs - Google Patents

Forme galenique pour la delivrance colique de principes actifs

Info

Publication number
FR2843301B1
FR2843301B1 FR0210151A FR0210151A FR2843301B1 FR 2843301 B1 FR2843301 B1 FR 2843301B1 FR 0210151 A FR0210151 A FR 0210151A FR 0210151 A FR0210151 A FR 0210151A FR 2843301 B1 FR2843301 B1 FR 2843301B1
Authority
FR
France
Prior art keywords
colic
delivery
active ingredients
galenic form
galenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0210151A
Other languages
English (en)
Other versions
FR2843301A1 (fr
Inventor
Sandrine Bourgeois
Elias Fattal
Antoine Andremont
Patrick Couvreur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Assistance Publique Hopitaux de Paris APHP
Da Volterra SAS
Universite Paris Cite
Universite Paris Saclay
Original Assignee
Centre National de la Recherche Scientifique CNRS
Da Volterra SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Da Volterra SAS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0210151A priority Critical patent/FR2843301B1/fr
Priority to FR0213514A priority patent/FR2843302B1/fr
Priority to ES03758212T priority patent/ES2327630T3/es
Priority to CN038213656A priority patent/CN1681480B/zh
Priority to JP2004528586A priority patent/JP2006500359A/ja
Priority to BR0313469-5A priority patent/BR0313469A/pt
Priority to AU2003274229A priority patent/AU2003274229B2/en
Priority to PCT/FR2003/002474 priority patent/WO2004016248A2/fr
Priority to EP03758212A priority patent/EP1526841B1/fr
Priority to AT03758212T priority patent/ATE432066T1/de
Priority to DE60327772T priority patent/DE60327772D1/de
Priority to EP20080163660 priority patent/EP1992336A3/fr
Priority to KR1020057002387A priority patent/KR101080577B1/ko
Priority to US10/524,318 priority patent/US7485294B2/en
Priority to MXPA05001607A priority patent/MXPA05001607A/es
Priority to CA002495291A priority patent/CA2495291A1/fr
Publication of FR2843301A1 publication Critical patent/FR2843301A1/fr
Application granted granted Critical
Publication of FR2843301B1 publication Critical patent/FR2843301B1/fr
Priority to US12/345,647 priority patent/US7833765B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0210151A 2002-08-09 2002-08-09 Forme galenique pour la delivrance colique de principes actifs Expired - Lifetime FR2843301B1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR0210151A FR2843301B1 (fr) 2002-08-09 2002-08-09 Forme galenique pour la delivrance colique de principes actifs
FR0213514A FR2843302B1 (fr) 2002-08-09 2002-10-29 Forme galenique pour la delivrance colique de principes actifs
EP20080163660 EP1992336A3 (fr) 2002-08-09 2003-08-06 Forme galénique pour la délivrance colique de principes actifs
JP2004528586A JP2006500359A (ja) 2002-08-09 2003-08-06 有効成分の結腸標的指向送達用ガレヌス製剤形態
BR0313469-5A BR0313469A (pt) 2002-08-09 2003-08-06 Forma galêmica para a liberação cólica de princìpios ativos
AU2003274229A AU2003274229B2 (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active ingredients
PCT/FR2003/002474 WO2004016248A2 (fr) 2002-08-09 2003-08-06 Forme galenique pour la delivrance colique de principes actifs
EP03758212A EP1526841B1 (fr) 2002-08-09 2003-08-06 Forme galenique pour la delivrance colique de principes actifs
ES03758212T ES2327630T3 (es) 2002-08-09 2003-08-06 Forma galenica para el suministro colico de principios activos.
DE60327772T DE60327772D1 (de) 2002-08-09 2003-08-06 Arzneimittel für die dickdarmverabreichung von wirkstoffen
CN038213656A CN1681480B (zh) 2002-08-09 2003-08-06 用于活性成分结肠靶向释放的盖仑制剂
KR1020057002387A KR101080577B1 (ko) 2002-08-09 2003-08-06 활성성분의 결장 표적화 전달을 위한 제제
US10/524,318 US7485294B2 (en) 2002-08-09 2003-08-06 Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof
MXPA05001607A MXPA05001607A (es) 2002-08-09 2003-08-06 Forma galenica para suministro de ingredientes activos dirigido al colon.
CA002495291A CA2495291A1 (fr) 2002-08-09 2003-08-06 Forme galenique pour la delivrance colique de principes actifs
AT03758212T ATE432066T1 (de) 2002-08-09 2003-08-06 Arzneimittel für die dickdarmverabreichung von wirkstoffen
US12/345,647 US7833765B2 (en) 2002-08-09 2008-12-29 Galenic formulation for colon-targeted delivery of active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0210151A FR2843301B1 (fr) 2002-08-09 2002-08-09 Forme galenique pour la delivrance colique de principes actifs

Publications (2)

Publication Number Publication Date
FR2843301A1 FR2843301A1 (fr) 2004-02-13
FR2843301B1 true FR2843301B1 (fr) 2004-10-22

Family

ID=30471041

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0210151A Expired - Lifetime FR2843301B1 (fr) 2002-08-09 2002-08-09 Forme galenique pour la delivrance colique de principes actifs

Country Status (1)

Country Link
FR (1) FR2843301B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006211996A1 (en) * 2005-02-09 2006-08-17 Centre National De La Recherche Scientifique Colonic delivery of active agents
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FR2950252B1 (fr) * 2009-09-23 2012-01-20 Centre Nat Rech Scient Forme galenique capable d'adsorber de maniere specifique les molecules indesirables
US20200138704A1 (en) * 2017-06-20 2020-05-07 Seattle Gummy Company Gelatin gummy compostion and methods of making and using thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention
US4963368A (en) * 1988-04-18 1990-10-16 Nabisco Brands, Inc. Oxidoreductase enzyme stabilized highly unsaturated fatty acids and derivatives of such acids
DK0454044T3 (da) * 1990-04-25 1996-04-22 Hoechst Ag Farmakologisk præparat indeholdende polyelektrolytkomplekser på mikropartikelform og mindst et virksomt stof
JPH0413741A (ja) * 1990-05-02 1992-01-17 Chisso Corp ペクチン・ポリリシン高分子電解質複合体
SE9002339L (sv) * 1990-07-04 1992-01-05 Kabi Pharmacia Ab Terapeutisk komposition och foerfarande foer dess framstaellning
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
WO1993013757A1 (fr) * 1992-01-17 1993-07-22 Alfatec-Pharma Gmbh Corps solides renfermant une matiere active, a structure composee de macromolecules hydrophiles, et leur procede de fabrication
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
US5718969A (en) * 1993-08-25 1998-02-17 Fmc Corporation Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation
WO1997027843A2 (fr) * 1996-01-30 1997-08-07 Advanced Polymer Systems, Inc. Apport cible de medicaments sur la partie inferieure du tractus gastro-intestinal

Also Published As

Publication number Publication date
FR2843301A1 (fr) 2004-02-13

Similar Documents

Publication Publication Date Title
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
SI1425277T1 (sl) Seäśninske spojine, aktivne kot vaniloidni receptorski antagonisti za zdravljenje boleäśine
WO2003105800A3 (fr) Forme galenique, se presentant sous forme de film adherant a la muqueuse, pour l'administration de principes actifs du cannabis
AU2003261167A1 (en) Liquid dosage compositions of stable nanoparticulate active agents
SK4070U (sk) Farmaceutická kompozícia na riadené uvoľňovanie účinných látok
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
FR2830447B1 (fr) Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
DK1526839T3 (da) Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed
EP1539122A4 (fr) Compositions pharmaceutiques de 2,6-diisopropylphenol aqueux
IL163725A0 (en) Administration of agents for the treatment of inflammation
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
FR2906140B1 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
EP1359927A4 (fr) Compositions phytopharmaceutiques utiles pour traiter des maladies immunologiques
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
WO2004098577A3 (fr) Forme posologique contenant du (s)-pantoprazole en tant qu'ingredient actif
FR2843301B1 (fr) Forme galenique pour la delivrance colique de principes actifs
TW200519102A (en) Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
MA27689A1 (fr) Forme galenique orale pour la liberation controlee de medicament
ITMI20022358A1 (it) Composizioni farmaceutiche effervescenti per la realizzazione di sospensioni non convenzionali.
FR2920308B1 (fr) Forme pharmaceutique pour l'administration par voie orale de principes actifs.
FR2849379B1 (fr) Encapsulation d'actifs liposolubles

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, FR

Effective date: 20120803

Owner name: UNIVERSITE DE PARIS DIDEROT-PARIS7, FR

Effective date: 20120803

Owner name: DA VOLTERRA, FR

Effective date: 20120803

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20120803

Owner name: UNIVERSITE PARIS SUD 11, FR

Effective date: 20120803

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

GC Lien (pledge) constituted

Effective date: 20170913

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20

TQ Partial transmission of property

Owner name: UNIVERSITE PARIS-SACLAY, FR

Effective date: 20220425

Owner name: UNIVERSITE DE PARIS DIDEROT-PARIS7, FR

Effective date: 20220425

Owner name: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, FR

Effective date: 20220425

Owner name: DA VOLTERRA, FR

Effective date: 20220425

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20220425

CD Change of name or company name

Owner name: UNIVERSITE PARIS CITE, FR

Effective date: 20221006

Owner name: UNIVERSITE PARIS-SACLAY, FR

Effective date: 20221006

Owner name: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, FR

Effective date: 20221006

Owner name: DA VOLTERRA, FR

Effective date: 20221006

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20221006